Loading…

Fixed Duration Daratumumab, Ixazomib, Lenalidomide, and Dexamethasone Quadruplet for Newly Diagnosed Multiple Myeloma - MRD Negativity and Survival Outcomes

Saved in:

Bibliographic Details
Published in:	Blood 2022-11, Vol.140 (Supplement 1), p.10142-10143
Main Authors:	Kumar, Shaji K, Laplant, Betsy, Asmus, Erik J, Buadi, Francis K., Gonsalves, Wilson I., Muchtar, Eli, Dingli, David, Thompson, Melanie Ann, Go, Ronald, Warsame, Rahma M, Kourelis, Taxiarchis, Hwa, Yi L., Fonder, Amie, Hobbs, Miriam A., Lacy, Martha Q., Dispenzieri, Angela, Hayman, Suzanne R., Leung, Nelson, Binder, Moritz, Rajkumar, S. Vincent, Gertz, Morie A, Kapoor, Prashant
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!